temozolomide has been researched along with Asthenia in 1 studies
Asthenia: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The results suggest that Cyberknife re-treatments are relatively safe using selected dose/fraction schemes." | 2.77 | Efficacy and toxicity of CyberKnife re-irradiation and "dose dense" temozolomide for recurrent gliomas. ( Arpa, D; Cardali, S; Conti, A; De Renzis, C; Granata, F; Pontoriero, A; Romanelli, P; Siragusa, C; Tomasello, C; Tomasello, F, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conti, A | 1 |
| Pontoriero, A | 1 |
| Arpa, D | 1 |
| Siragusa, C | 1 |
| Tomasello, C | 1 |
| Romanelli, P | 1 |
| Cardali, S | 1 |
| Granata, F | 1 |
| De Renzis, C | 1 |
| Tomasello, F | 1 |
1 trial available for temozolomide and Asthenia
| Article | Year |
|---|---|
Efficacy and toxicity of CyberKnife re-irradiation and "dose dense" temozolomide for recurrent gliomas.
Topics: Antineoplastic Agents, Alkylating; Asthenia; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Fe | 2012 |